Navigation Links
Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011
Date:11/8/2011

BETHESDA, Md., Nov. 8, 2011 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: CHDX), an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced financial results for the third quarter and first nine months of 2011 ended September 30, 2011.

Third Quarter 2011 Financial Highlights

  • Revenue from healthcare services increased 23% to $28.8 million from $23.4 million in the prior year period.
  • Adjusted EBITDA rose to $4.3 million, compared to Adjusted EBITDA of $3.5 million in the prior year period.
  • Income from operations was $490,000 compared to $4.8 million in the prior year period.
  • Net income was $315,000, or $0.02 per diluted share, compared to net income of $3.2 million, or $0.20 per diluted share, in the prior year period.
  • Development, pre-opening and start-up expense was $2.4 million compared to $653,000 in the prior year period.

  • Roberta Lipson, President and CEO of Chindex, commented, "We are pleased with the strong revenue and profitability growth achieved during the third quarter of 2011. Revenue rose 23% year-over-year to $28.8 million, putting Chindex well on-track to deliver mid-teens revenue growth for the full year of 2011. Furthermore, we saw our Adjusted EBITDA grow 23% year-over-year to $4.3 million demonstrating our ability to generate strong returns for shareholders through our existing facilities."

    "We are also pleased with the progress of our hospital expansion plans, our primary focus in 2011," Ms. Lipson continued. "China's hospital services market is heavily regulated by government licensing and approval. This means that there is a certain level of volatility built into the system. We are proud of our team's ability to navigate the complicated approval and construction process. At the same time, we will adapt our guidance of expansion timelines to better fit market dynamics by focusing on progress of near term projects. We continue to be extremely excited by our ongoing projects. They will enhance our current facilities with added capacity and service offerings and are well-timed to capitalize upon current policy support for private investment in healthcare as well as the growing affluence of China's population."

    Third Quarter 2011 Financial ResultsThird quarter 2011 revenue from healthcare services increased 23% to $28.8 million from $23.4 million in the prior year period, reflecting continued growth of inpatient and outpatient volume across the United Family Healthcare network as well as nascent contributions from the phased opening of the Beijing United Family expansion. Outpatient services contributed 58% of revenue and inpatient services contributed 42% of revenue in the third quarter of 2011, compared to 60% and 40%, respectively, in the year ago period. By service line, surgical services contributed 19%, OB/GYN contributed 16%, pediatrics contributed 7%, ancillary services contributed 33% and other services contributed 25% of revenue.

    Operating expenses for the three months ended September 30, 2011 increased 34% to $28.3 million from $21.1 million in the prior year period primarily reflecting the Company's ongoing expansion efforts. Salaries, wages and benefits in the third quarter of 2011 increased 30% to $16.5 million from $12.7 million in the prior year period reflecting a 20% increase in headcount to drive revenue growth and support development activities. Development, pre- and post-opening and start up expenses for the Beijing United expansion, Shanghai Pudong expansion, Tianjin United project and Beijing United Family Rehabilitation Hospital were $2.4 million this quarter. Operating expenses also included certain non-cash expenses including $878,000 of stock compensation expense compared to $375,000 for the prior year period.

    Adjusted EBITDA in the third quarter of 2011 increased to approximately $4.3 million compared to $3.5 million in the prior year period driven by strong revenue growth and consistent profitability of existing facilities.

    Income from operations was $490,000 compared to income from operations of $4.8 million in the prior year period.

    The Company recorded a $791,000 provision for taxes in the third quarter of 2011 compared to a provision for taxes of $1.5 million in the prior year period.

    Net income for the quarter ended September 30, 2011 was $315,000, or $0.02 per diluted share, compared to $3.2 million, or $0.20 per diluted share, in the prior year period. For the third quarter of 2011, weighted average diluted shares outstanding were 17.3 million.

    First Nine Months of 2011 Financial ResultsDuring the first nine months of 2011, revenue from healthcare services increased 19% to $82.5 million from $69.3 million in the prior year period, reflecting growing inpatient and outpatient volume across the United Family Healthcare network. Outpatient services contributed 59% of revenue and inpatient services contributed 41% of revenue in the first nine months of 2011 compared to 60% and 40%, respectively, in the year ago period. By service line, surgical services contributed 18%, OB/GYN contributed 15%, pediatrics contributed 8%, ancillary services contributed 33% and other services contributed 26% of revenue.

    Operating expenses for the first nine months of 2011 increased 26% to $78.9 million from $62.8 million in the prior year period primarily due to increased staffing, office and administrative supplies associated with the Company's ongoing development and expansion plans. Development, pre-opening and start up expenses, including post-opening expenses, rose to $5.2 million from $1.5 million in the prior year period primarily as a result of expenses related to the Company's Beijing, Pudong and Tianjin projects. Operating expenses also included certain non-cash expenses including $2.5 million of non-cash stock compensation expense.

    Adjusted EBITDA was approximately $12.8 million compared to $9.8 million in the prior year period.

    Income from operations was $3.6 million compared to income from operations of $7.9 million in the prior year period.

    Provision for taxes was $2.9 million compared to $3.3 million in the prior year period.

    Net income was $2.0 million, or $0.13 per diluted share, compared to net income of $4.6 million, or $0.29 per diluted share, in the prior year period. For the first nine months of 2011 ended September 30, 2011, weighted average diluted shares outstanding were 17.4 million.

    As of September 30, 2011, the Company had $67.4 million in cash and cash equivalents and investments.

    Non-GAAP MeasuresThe Company presents Adjusted EBITDA to better illustrate ongoing operational results. Adjusted EBITDA is defined as income (loss) before interest expense, income taxes, depreciation and amortization, and also excludes development, pre-opening and start-up expenses related to new and pending hospitals and clinics, equity in earnings (loss) income of unconsolidated affiliate, non-recurring charges for Chindex Medical Limited (CML) joint venture formation and effect of change in corporate cost allocations. The Company anticipates recurring development, pre-opening and start-up expense and notes that such expense is a basic element of the long term growth plan. Management believes that providing an Adjusted EBITDA analysis to investors is a helpful metric to better illustrate the Company's operations, including development plans, and changes in presentation from historical periods. The Company uses Adjusted EBITDA for business planning and other purposes. Other companies may calculate Adjusted EBITDA differently, and therefore Chindex's Adjusted EBITDA may not be comparable to similarly titled measures of other companies. Adjusted EBITDA is not a measure of financial performance under U.S. generally accepted accounting principles (GAAP), and should not be considered in isolation or as an alternative to net income (loss), cash flows from operating activities and other measures determined in accordance with GAAP. Items excluded from Adjusted EBITDA are significant and necessary components to the operations of the Company's business, and, therefore, Adjusted EBITDA should only be used as a supplemental measure of operating performance.

    Chindex Medical LimitedThe Chindex Medical Limited joint venture (CML) between FosunPharma and Chindex International began operations on January 1, 2011. The strategic venture merged the former Medical Products division of Chindex International and select medical device companies of FosunPharma. FosunPharma owns 51% and Chindex owns 49% of the CML joint venture. Chindex recognizes its 49% interest in CML's net income using the equity method of accounting.

    Accordingly, for the quarter and nine months ended September 30, 2011, the Company recognized $539,000 and $1.1 million, respectively, for its 49% share of CML. In recognizing its 49% interest in the net income of CML for the quarter, Chindex also included additional expenses for amortization of certain fair value adjustments made in connection with the formation of the joint venture.

    Conference CallManagement will host a conference call at 8:00 am ET on November 9, 2011, to discuss financial results. To participate in the conference call, U.S. domestic callers may dial 1-877-303-9231 and international callers may dial 1-760-666-3567 approximately 10 minutes before the conference call is scheduled to begin. A telephone replay will be available from the day of the call until November 16, 2011 by dialing (U.S. domestic) 1-855-859-2056 or (international) 1-404-537-3406, passcode 20653790. A webcast of the earnings call will be accessible via Chindex's website at http://ir.chindex.com/events.cfm.

    About Chindex International, Inc.Chindex is an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare currently operates in Beijing, Shanghai and Guangzhou. The Company also provides medical capital equipment and products through Chindex Medical Ltd., a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. With thirty years of experience, the Company's strategy is to continue its growth as a leading integrated health care provider in the Greater China region. Further company information may be found at the Company's website at http://www.chindex.com.

    Safe Harbor Statement

    Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in the Company's Transition Report on Form 10-K for the nine months ended December 31, 2010, updates and additions to those "Risk Factors" in the Company's interim reports on Form 10-Q, Forms 8-K and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue" or similar terms or the negative of these terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. The Company has no obligation to update these forward-looking statements.Contact:ICR, Inc.Ashley De Simone(646) 277-1227- Financial Summary Attached -

    CHINDEX INTERNATIONAL, INC.CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS(in thousands except share and per share data)Three months ended September 30,Nine months ended September 30,2011201020112010RevenueHealthcare services revenue

    $28,815

    $23,361

    $82,465

    $69,278Product sales

    -

    21,813

    -

    58,640Total revenue

    28,815

    45,174

    82,465

    127,918Operating expensesHealthcare services:Salaries, wages and benefits

    16,540

    12,718

    46,768

    38,364Other operating expenses

    4,962

    3,962

    13,518

    10,615Supplies and purchased medical services

    3,247

    2,281

    9,109

    6,915Bad debt expense

    466

    198

    1,396

    1,139Depreciation and amortization

    1,459

    955

    3,653

    2,762Lease and rental expense

    1,651

    1,009

    4,450

    2,96928,325

    21,123

    78,894

    62,764Products:Product sales costs

    -

    15,111

    -

    41,308Product selling and other operating expenses

    -

    4,109

    -

    15,987-

    19,220

    -

    57,295Total operating expenses

    28,325

    40,343

    78,894

    120,059Income from operations

    490

    4,831

    3,571

    7,859 Other income and (expenses)Interest income

    192

    108

    552

    410Interest expense

    (109)

    (212)

    (290)

    (619)Equity in income of unconsolidated affiliate

    539

    -

    1,121

    -Miscellaneous (expense) income  - net

    (6)

    7

    (73)

    238Income before income taxes

    1,106

    4,734

    4,881

    7,888Provision for income taxes

    (791)

    (1,497)

    (2,853)

    (3,300)Net income

    $315

    $3,237

    $2,028

    $4,588Net income per common share - basic

    $.02

    $.21

    $.13

    $.31Weighted average shares outstanding - basic

    16,134,459

    15,213,124

    16,113,426

    14,908,644Net income per common share - diluted

    $.02

    $.20

    $.13

    $.29Weighted average shares outstanding - diluted

    17,250,548

    16,582,181

    17,411,770

    16,371,293CHINDEX INTERNATIONAL, INC.CONSOLIDATED CONDENSED BALANCE SHEETS(in thousands except share data)September 30, 2011December 31, 2010ASSETSCurrent assets: Cash and cash equivalents

    $27,554

    $32,007 Restricted cash

    -

    300 Investments

    39,294

    37,631Accounts receivable, less allowance for doubtful accounts of $8,220 and $6,748,

    respectively

    14,272

    11,601Receivables from affiliate

    6,417

    9.330 Inventories, net

    1.763

    1,413 Deferred income taxes

    4,259

    3,242 Other current assets

    2,836

    3,856Total current assets

    96,395

    99,380Restricted cash and sinking funds

    1,021

    980Investments

    507

    2,439Investment in unconsolidated affiliate

    32,877

    31,756Property and equipment, net

    50,930

    37,099Noncurrent deferred income taxes

    471

    108Other assets

    2,965

    2,411Total assets

    $185,166

    $174,173LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

    $3,314

    $4,038Payable to affiliate

    946

    -Accrued expenses

    10,620

    8,541Other current liabilities

    4,885

    3,874Income taxes payable

    1,948

    2,147Total current liabilities

    21,713

    18,600Long-term debt and convertible debentures

    23,669

    23,070Long-term deferred tax liability

    431

    431Total liabilities

    45,813

    42,101Commitments and contingenciesStockholders' equity:    Preferred stock, $.01 par value, 500,000 shares authorized, none issued

    -

    -   Common stock, $.01 par value, 28,200,000 shares authorized, including 3,200,000 designated Class B:Common stock – 15,630,018 and 15,310,426 shares issued andoutstanding at September 30, 2011 and December 31, 2010, respectively

    156

    153 Class B stock – 1,162,500 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively

    12

    12   Additional paid-in capital

    118,369

    115,815Accumulated other comprehensive income

    7,498

    4,802Retained earnings

    13,318

    11,290Total stockholders' equity

    139,353

    132,072Total liabilities and stockholders' equity

    $185,166

    $174,173CHINDEX INTERNATIONAL, INC.CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS(in thousands)Nine months ended September 30, 20112010OPERATING ACTIVITIESNet income

    $

    2,028

    $

    4,588Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization3,6532,946Provision for demonstration inventory-463Inventory write down675Provision for doubtful accounts1,3961,284Loss on disposal of property and equipment7861Equity in income of unconsolidated affiliate(1,121)-Deferred income taxes(1,257)116Stock based compensation2,5471,893Foreign exchange (gain) loss(482)923Amortization of debt issuance costs77Amortization of debt discount186186Non-cash charge for change in fair value of warrants-(224)Changes in operating assets and liabilities:Restricted cash300(1,113)Accounts receivable(3,511)5,983Accounts receivable from affiliate2,913-Inventories(290)(4,231)Other current assets and other assets623(185)Accounts payable, accrued expenses, other current liabilities and deferred revenue(3,859)1,254Accounts payable to affiliate946-Income taxes payable(257)(933)Net cash provided by operating activities3,90613,093INVESTING ACTIVITIESPurchases of short-term investments and CDs(23,518)(6,208)Proceeds from redemption of CDs24,17922,341Purchases of property and equipment(9,743)(12,967)Net cash (used in) provided by investing activities(9,082)3,166FINANCING ACTIVITIESRepayment of debt, sinking fund deposits and vendor financing-(1,748)Repurchase of restricted stock for income tax withholding(104)(943)Proceeds from issuance of common stock-13,803Proceeds from exercise of stock options and warrants114577Net cash provided by financing activities1011,689Effect of foreign exchange rate changes on cash and cash equivalents713871Net (decrease) increase in cash and cash equivalents(4,453)28,819Cash and cash equivalents at beginning of period32,00723,760Cash and cash equivalents at end of period

    $

    27,554

    $

    52,579Supplemental disclosures of cash flow information:Cash paid for interest

    $

    649

    $

    641Cash paid for taxes

    $

    4,433

    $

    4,770Non-cash investing and financing activities consist of the following:Property and equipment additions included in accounts payable

    $

    6,304

    $

    1,497Cashless exercise of warrants at fair value

    $

    -

    $

    800Exercise of warrants at fair value

    $

    -

    $

    (201)The table below reconciles our consolidated net income to Adjusted EBITDA (in thousands)Three months ended September 30,Nine months ended September 30,2011201020112010Consolidated net income

    $315

    $3,237

    $2,028

    $4,588Adjustments:Depreciation and amortization

    1,459

    955

    3,653

    2,762Provision for income taxes

    791

    1,497

    2,853

    3,300Interest expense

    109

    212

    290

    619Interest and other income, net

    (186)

    (115)

    (479)

    (648)Development, pre-opening and start-up expense

    2,392

    653

    5,182

    1,454Equity in earnings of unconsolidated affiliate

    (539)

    -

    (1,121)

    -Non-recurring charges for CML JV formation

    -

    -

    400

    -Effect of change in corporate cost allocations

    -

    (325)

    -

    (975)4,026

    2,877

    10,778

    6,512Adjustments to exclude Medical Products Division:Medical Products revenue

    -

    (21,813)

    -

    (58,640)Medical Products cost of products sold

    -

    15,111

    -

    41,308Medical Products selling and operating expenses

    -

    4,109

    -

    15,987-

    (2,593)

    -

    (1,345)Adjusted EBITDA

    $4,341

    $3,521

    $12,806

    $9,755
    '/>"/>

    SOURCE Chindex International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved


    Related medicine technology :

    1. Chindex International, Inc. to Report Financial Results for the Third Quarter and First Nine Months of 2011
    2. Chindex International, Inc. to Attend Nomura Healthcare Corporate Day
    3. Chindex International, Inc. Announces Participation in Upcoming Investor Conferences
    4. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011
    5. Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011
    6. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
    7. Chindex International, Inc. Reports First Quarter 2011 Financial Results
    8. Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010
    9. Chindex International to Report Financial Results for the Three and Nine-Month Periods Ended December 31, 2010
    10. Chindex and Fosun Pharma Form Joint Venture
    11. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
    (Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
    (Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
    (Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
    (Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
    (Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
    Breaking Medicine News(10 mins):